These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 10741546)
41. Synthesis and biological evaluation of a series of quinazoline-2-carboxylic acids and quinazoline-2,4-diones as glycine-NMDA antagonists: a pharmacophore model based approach. Colotta V; Catarzi D; Varano F; Cecchi L; Filacchioni G; Galli A; Costagli C Arch Pharm (Weinheim); 1997 May; 330(5):129-34. PubMed ID: 9237424 [TBL] [Abstract][Full Text] [Related]
42. Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine. Peeters M; Gunthorpe MJ; Strijbos PJ; Goldsmith P; Upton N; James MF J Pharmacol Exp Ther; 2007 May; 321(2):564-72. PubMed ID: 17267580 [TBL] [Abstract][Full Text] [Related]
43. Tetrahydro-3-benzazepines with fluorinated side chains as NMDA and σ Thum S; Schepmann D; Ayet E; Pujol M; Nieto FR; Ametamey SM; Wünsch B Eur J Med Chem; 2019 Sep; 177():47-62. PubMed ID: 31129453 [TBL] [Abstract][Full Text] [Related]
50. Design and synthesis of a novel water-soluble NMDA receptor antagonist with a 1,4,7,10-tetraazacyclododecane group. Masuko T; Metori K; Kizawa Y; Kusama T; Miyake M Chem Pharm Bull (Tokyo); 2005 Apr; 53(4):444-7. PubMed ID: 15802850 [TBL] [Abstract][Full Text] [Related]
51. Influence of extracellular pH on inhibition by ifenprodil at N-methyl-D-aspartate receptors in Xenopus oocytes. Pahk AJ; Williams K Neurosci Lett; 1997 Mar; 225(1):29-32. PubMed ID: 9143010 [TBL] [Abstract][Full Text] [Related]
52. Role of NR2B-containing N-methyl-D-aspartate receptors in haloperidol-induced c-Fos expression in the striatum and nucleus accumbens. Lee J; Rajakumar N Neuroscience; 2003; 122(3):739-45. PubMed ID: 14622917 [TBL] [Abstract][Full Text] [Related]
53. 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity. Carling RW; Leeson PD; Moore KW; Moyes CR; Duncton M; Hudson ML; Baker R; Foster AC; Grimwood S; Kemp JA; Marshall GR; Tricklebank MD; Saywell KL J Med Chem; 1997 Feb; 40(5):754-65. PubMed ID: 9057862 [TBL] [Abstract][Full Text] [Related]
54. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit. Chaperon F; Müller W; Auberson YP; Tricklebank MD; Neijt HC Behav Pharmacol; 2003 Sep; 14(5-6):477-87. PubMed ID: 14501261 [TBL] [Abstract][Full Text] [Related]
55. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor. Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859 [TBL] [Abstract][Full Text] [Related]
56. Azagrevellins, Part I. Grevellin analogs with affinity to the N-methyl-D-aspartate (glycine site) receptor, a novel lead structure. Poschenrieder H; Höfner G; Stachel HD Arch Pharm (Weinheim); 2000 Jul; 333(7):211-6. PubMed ID: 10965595 [TBL] [Abstract][Full Text] [Related]